.gen Technologies Inc.

The San Diego Business Journal summarizes local biotech giants Illumina and Life Technologies’ race to the $1000 genome. Spoiler alert – analysts favor Illumina’s Solexa technology over Life Tech’s SOLiD.
 
http://www.sdbj.com/article.asp?aID=144667&link=perm

The Economist weighs in on the political chances of healthcare reform in the US. In a nutshell, there’s an outside chance the House will pass the Senate bill then modify, but it’s more likely it will all wither like Hillarycare.
 
In the meantime, the ARRA HITECH provisions for moving doctors to Electronic Medical Records (EMRs) stand, so we can continue to expect more money to flow into Healthcare IT.
 
NOTE: Link may be under subscription for the remainder of this week.
 
http://www.economist.com/world/united-states/displaystory.cfm?story_id=15453116

Local biotech Isis Pharmaceuticals reports strong results for their cholesterol therapy mipomersen, at the same time broadening potential patients from those that are homozygous for familial hypercholesterolemia to those who are heterozygous as well. Isis and partner Genzyme plan to move this treatment to market in 2011.